Integrum expands its product offering into the Israeli market
Mölndal, Sweden – March 26, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a commercial agreement with AMI Technologies, a leading local medical device distributor, to introduce the OPRATM Implant System in Israel.
As part of Integrum's efforts to expand the availability of the OPRA™ Implant System to new geographical markets, the company has as of today started a collaboration in Israel with AMI Technologies (www.ami.co.il).
“The collaboration with AMI Technologies secures a swift launch of OPRA™ Implant System in Israel and shortens the distance between us and patients needing reconstructive surgery. We see a large need for our innovative products in the region and hope we can help improve the quality of life for amputees,” says Rickard Brånemark, CEO of Integrum.